The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose
- PMID: 30885145
- PMCID: PMC6421686
- DOI: 10.1186/s12876-019-0958-4
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose
Abstract
Background: Metabolic disorders such as insulin resistance, obesity, and hyperglycemia are prominent risk factors for the development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH). Dietary rodent models employ high fat, high cholesterol, high fructose, methionine/choline deficient diets or combinations of these to induce NAFLD/NASH. The FATZO mice spontaneously develop the above metabolic disorders and type 2 diabetes (T2D) when fed with a normal chow diet. The aim of the present study was to determine if FATZO mice fed a high fat and fructose diet would exacerbate the progression of NAFLD/NASH.
Methods: Male FATZO mice at the age of 8 weeks were fed with high fat Western diet (D12079B) supplemented with 5% fructose in the drinking water (WDF) for the duration of 20 weeks. The body weight, whole body fat content, serum lipid profiles and liver function markers were examined monthly along with the assessment of liver histology for the development of NASH. In addition, the effects of obeticholic acid (OCA, 30 mg/kg, QD) on improvement of NASH progression in the model were evaluated.
Results: Compared to normal control diet (CD), FATZO mice fed with WDF were heavier with higher body fat measured by qNMR, hypercholesterolemia and had progressive elevations in AST (~ 6 fold), ALT (~ 6 fold), liver over body weight (~ 2 fold) and liver triglyceride (TG) content (1.4-2.9 fold). Histological examination displayed evidence of NAFLD/NASH, including hepatic steatosis, lobular inflammation, ballooning and fibrosis in FATZO mice fed WDF. Treatment with OCA for 15 weeks in FATZO mice on WDF significantly alleviated hypercholesterolemia and elevation of AST/ALT, reduced liver weight and liver TG contents, attenuated hepatic ballooning, but did not affect body weight and blood TG levels.
Conclusion: WDF fed FATZO mice represent a new model for the study of progressive NAFLD/NASH with concurrent metabolic dysregulation.
Keywords: FATZO mouse; Liver disease; Metabolic disease; NAFLD; NASH.
Conflict of interest statement
Ethics approval
All animal experiments in the study were approved by the Institutional Animal Care and Use Committee at Crown Bioscience – Indiana (IACUC protocol number: 2015–230).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures










Similar articles
-
Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF).BMC Gastroenterol. 2020 Oct 15;20(1):339. doi: 10.1186/s12876-020-01467-w. BMC Gastroenterol. 2020. PMID: 33059584 Free PMC article.
-
A new method to induce nonalcoholic steatohepatitis (NASH) in mice.BMC Gastroenterol. 2019 Jul 15;19(1):125. doi: 10.1186/s12876-019-1041-x. BMC Gastroenterol. 2019. PMID: 31307427 Free PMC article.
-
Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.J Transl Med. 2019 Apr 3;17(1):110. doi: 10.1186/s12967-019-1854-y. J Transl Med. 2019. PMID: 30943987 Free PMC article.
-
[Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis].Nihon Eiseigaku Zasshi. 2015;70(3):197-204. doi: 10.1265/jjh.70.197. Nihon Eiseigaku Zasshi. 2015. PMID: 26411937 Review. Japanese.
-
A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.Molecules. 2022 Jan 27;27(3):858. doi: 10.3390/molecules27030858. Molecules. 2022. PMID: 35164140 Free PMC article. Review.
Cited by
-
Heterogeneous effects of individual high-fat diet compositions on phenotype, metabolic outcome, and hepatic proteome signature in BL/6 male mice.Nutr Metab (Lond). 2023 Feb 8;20(1):8. doi: 10.1186/s12986-023-00729-0. Nutr Metab (Lond). 2023. PMID: 36755289 Free PMC article.
-
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model.Life (Basel). 2022 Dec 29;13(1):100. doi: 10.3390/life13010100. Life (Basel). 2022. PMID: 36676050 Free PMC article.
-
Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research.Int J Mol Sci. 2022 Dec 13;23(24):15791. doi: 10.3390/ijms232415791. Int J Mol Sci. 2022. PMID: 36555433 Free PMC article. Review.
-
Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis.Adv Sci (Weinh). 2020 Nov 9;7(24):2002997. doi: 10.1002/advs.202002997. eCollection 2020 Dec. Adv Sci (Weinh). 2020. PMID: 33344141 Free PMC article.
-
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal.J Clin Med. 2020 Dec 24;10(1):36. doi: 10.3390/jcm10010036. J Clin Med. 2020. PMID: 33374435 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous